149 related articles for article (PubMed ID: 31822972)
21. Comprehensive evaluation of methods to assess overall and cell-specific immune infiltrates in breast cancer.
Nederlof I; De Bortoli D; Bareche Y; Nguyen B; de Maaker M; Hooijer GKJ; Buisseret L; Kok M; Smid M; Van den Eynden GGGM; Brinkman AB; Hudecek J; Koster J; Sotiriou C; Larsimont D; Martens JWM; van de Vijver MJ; Horlings HM; Salgado R; Biganzoli E; Desmedt C
Breast Cancer Res; 2019 Dec; 21(1):151. PubMed ID: 31878981
[TBL] [Abstract][Full Text] [Related]
22. Abundant tumor infiltrating lymphocytes after primary systemic chemotherapy predicts poor prognosis in estrogen receptor-positive/HER2-negative breast cancers.
Watanabe T; Hida AI; Inoue N; Imamura M; Fujimoto Y; Akazawa K; Hirota S; Miyoshi Y
Breast Cancer Res Treat; 2018 Feb; 168(1):135-145. PubMed ID: 29168063
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of the Predictive and Prognostic Values of Stromal Tumor-Infiltrating Lymphocytes in HER2-Positive Breast Cancers treated with neoadjuvant chemotherapy.
Yang X; Rao J; Yang W; Shui R
Target Oncol; 2018 Dec; 13(6):757-767. PubMed ID: 30406444
[TBL] [Abstract][Full Text] [Related]
24. The Role of Combined Diffusion-Weighted Imaging and Dynamic Contrast-Enhanced MRI for Differentiating Malignant From Benign Breast Lesions Presenting Washout Curve.
Tezcan S; Ozturk FU; Uslu N; Akcay EY
Can Assoc Radiol J; 2021 Aug; 72(3):460-469. PubMed ID: 32157892
[TBL] [Abstract][Full Text] [Related]
25. Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer Subtypes.
Ni Y; Tsang JY; Shao Y; Poon IK; Tam F; Shea KH; Tse GM
Oncologist; 2022 Apr; 27(4):e313-e327. PubMed ID: 35380716
[TBL] [Abstract][Full Text] [Related]
26. Associations Between ADC Texture Analysis and Tumor Infiltrating Lymphocytes in Brain Metastasis - A Preliminary Study.
Meyer HJ; Hohn AK; Prasse G; Hoffmann KT; Surov A
Anticancer Res; 2021 Sep; 41(9):4549-4554. PubMed ID: 34475082
[TBL] [Abstract][Full Text] [Related]
27. Diffusion-weighted magnetic resonance imaging of thymoma: ability of the Apparent Diffusion Coefficient in predicting the World Health Organization (WHO) classification and the Masaoka-Koga staging system and its prognostic significance on disease-free survival.
Priola AM; Priola SM; Giraudo MT; Gned D; Fornari A; Ferrero B; Ducco L; Veltri A
Eur Radiol; 2016 Jul; 26(7):2126-38. PubMed ID: 26427698
[TBL] [Abstract][Full Text] [Related]
28. Stromal tumor-infiltrating lymphocytes level as a prognostic factor for resected intrahepatic cholangiocarcinoma and its prediction by apparent diffusion coefficient.
Miyazaki K; Morine Y; Yamada S; Saito Y; Tokuda K; Okikawa S; Yamashita S; Oya T; Ikemoto T; Imura S; Hu H; Morioka H; Tsuneyama K; Shimada M
Int J Clin Oncol; 2021 Dec; 26(12):2265-2274. PubMed ID: 34596803
[TBL] [Abstract][Full Text] [Related]
29. Role of Cytotoxic Tumor-Infiltrating Lymphocytes in Predicting Outcomes in Metastatic HER2-Positive Breast Cancer: A Secondary Analysis of a Randomized Clinical Trial.
Liu S; Chen B; Burugu S; Leung S; Gao D; Virk S; Kos Z; Parulekar WR; Shepherd L; Gelmon KA; Nielsen TO
JAMA Oncol; 2017 Nov; 3(11):e172085. PubMed ID: 28750133
[TBL] [Abstract][Full Text] [Related]
30. Prognostic and predictive value of tumor-infiltrating lymphocytes in two phase III randomized adjuvant breast cancer trials.
Dieci MV; Mathieu MC; Guarneri V; Conte P; Delaloge S; Andre F; Goubar A
Ann Oncol; 2015 Aug; 26(8):1698-704. PubMed ID: 25995301
[TBL] [Abstract][Full Text] [Related]
31. Stromal Tumor Infiltrating Lymphocytes (sTIL) as an Independent Predictor of Pathologic Response to Neadjuvant Chemotherapy in Breast Cancer in Indonesia: A Hospital-based Study.
Felicia D; Hellyanti T
Asian Pac J Cancer Prev; 2022 Aug; 23(8):2763-2769. PubMed ID: 36037132
[TBL] [Abstract][Full Text] [Related]
32. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
[TBL] [Abstract][Full Text] [Related]
33. Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies.
Hida AI; Sagara Y; Yotsumoto D; Kanemitsu S; Kawano J; Baba S; Rai Y; Oshiro Y; Aogi K; Sagara Y; Ohi Y
Breast Cancer Res Treat; 2016 Jul; 158(1):1-9. PubMed ID: 27260189
[TBL] [Abstract][Full Text] [Related]
34. Tumor apparent diffusion coefficient as an imaging biomarker to predict tumor aggressiveness in patients with estrogen-receptor-positive breast cancer.
Shin HJ; Kim SH; Lee HJ; Gong G; Baek S; Chae EY; Choi WJ; Cha JH; Kim HH
NMR Biomed; 2016 Aug; 29(8):1070-8. PubMed ID: 27332719
[TBL] [Abstract][Full Text] [Related]
35. Tumor-infiltrating lymphocytes (TILs)/volume and prognosis: The value of TILs for survival in HER2 and TN breast cancer patients treated with chemotherapy.
Okcu O; Öztürk SD; Öztürk Ç; Şen B; Yasin Aİ; Bedir R
Ann Diagn Pathol; 2022 Jun; 58():151930. PubMed ID: 35245821
[TBL] [Abstract][Full Text] [Related]
36. A nomogram to predict pathologic complete response (pCR) and the value of tumor-infiltrating lymphocytes (TILs) for prediction of response to neoadjuvant chemotherapy (NAC) in breast cancer patients.
Hwang HW; Jung H; Hyeon J; Park YH; Ahn JS; Im YH; Nam SJ; Kim SW; Lee JE; Yu JH; Lee SK; Choi M; Cho SY; Cho EY
Breast Cancer Res Treat; 2019 Jan; 173(2):255-266. PubMed ID: 30324273
[TBL] [Abstract][Full Text] [Related]
37. Stromal fibrosis: imaging features with diagnostic contribution of diffusion-weighted MRI.
Yilmaz R; Bayramoglu Z; Kartal MG; Çaliskan E; Salmaslıoglu A; Dursun M; Acunas G
Br J Radiol; 2018 May; 91(1085):20170706. PubMed ID: 29388800
[TBL] [Abstract][Full Text] [Related]
38. Prognostic Significance of Stromal and Intraepithelial Tumor-Infiltrating Lymphocytes in Small Intestinal Adenocarcinoma.
Jun SY; Park ES; Lee JJ; Chang HK; Jung ES; Oh YH; Hong SM
Am J Clin Pathol; 2020 Jan; 153(1):105-118. PubMed ID: 31576398
[TBL] [Abstract][Full Text] [Related]
39. Immune characterization of breast cancer metastases: prognostic implications.
Dieci MV; Tsvetkova V; Orvieto E; Piacentini F; Ficarra G; Griguolo G; Miglietta F; Giarratano T; Omarini C; Bonaguro S; Cappellesso R; Aliberti C; Vernaci G; Giorgi CA; Faggioni G; Tasca G; Conte P; Guarneri V
Breast Cancer Res; 2018 Jun; 20(1):62. PubMed ID: 29929548
[TBL] [Abstract][Full Text] [Related]
40. Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.
Romagnoli G; Wiedermann M; Hübner F; Wenners A; Mathiak M; Röcken C; Maass N; Klapper W; Alkatout I
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28885584
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
